Atıf Formatları
Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. Beyazal Polat Et Al. , "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19," European Journal of Clinical and Experimental Medicine , vol.22, 2024

Beyazal Polat, H. Et Al. 2024. Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19. European Journal of Clinical and Experimental Medicine , vol.22 .

Beyazal Polat, H., Arpa, M., Polat, Z., Beyazal, M., Beyazal Çeliker, F., Ayaz, T., ... Ertürk, A.(2024). Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19. European Journal of Clinical and Experimental Medicine , vol.22.

Beyazal Polat, HATİCE Et Al. "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19," European Journal of Clinical and Experimental Medicine , vol.22, 2024

Beyazal Polat, HATİCE B. Et Al. "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19." European Journal of Clinical and Experimental Medicine , vol.22, 2024

Beyazal Polat, H. Et Al. (2024) . "Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19." European Journal of Clinical and Experimental Medicine , vol.22.

@article{article, author={HATİCE BEYAZAL POLAT Et Al. }, title={Prognostic significance of C-reactive protein/albumin and neutrophil/lymphocyte ratios in patients with COVID-19}, journal={European Journal of Clinical and Experimental Medicine}, year=2024}